# NervGen Pharma Corp. Common stock (NGEN)

> Healthcare · CA · Reports in CAD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NGEN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -44.12M | $ -19.50M | $ 8.4K | $ 3.48M |
| 2024 | $ 0 | $ -17.67M | $ -12.48M | $ 73.4K | $ 1.79M |
| 2023 | $ 0 | $ -17.37M | $ -8.75M | $ 148.8K | $ -1.52M |
| 2022 | $ 0 | $ -16.93M | $ -14.45M | $ 209.1K | $ 9.93M |
| 2021 | $ 0 | $ -11.53M | $ -7.50M | $ 0 | $ 13.30M |
| 2020 | $ 0 | $ -10.06M | $ -5.60M | $ 0 | $ 4.65M |
| 2019 | $ 0 | $ -8.93M | $ -5.45M | $ 0 | $ 4.50M |
| 2018 | $ 0 | $ -1.25M | $ -923.8K | $ 0 | $ 1.84M |
| 2017 | $ 0 | $ -6.4K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 5.68 |
| Current Ratio | 1.16 |

## Other views

- [Metrics](https://sponda.capital/en/NGEN.md)
- [Charts](https://sponda.capital/en/NGEN/charts.md)
- [Compare](https://sponda.capital/en/NGEN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.